SAM #75N98026R00148

NIH NINDS Seeks SME Consulting for Gene-Based Therapeutics Development

The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), is seeking expert consulting services to advance gene-based therapeutics development. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) - Services Requested: - Subject matter expert (SME) consulting for gene-based therapeutics, focusing on chemistry, manufacturing, and controls (CMC) for biologics - Expertise required in synthetic oligonucleotides, including antisense oligonucleotides (ASO) and small interfering RNAs (siRNA) - Consultants will provide technical advice, regulatory support, and participate in multidisciplinary teams for NIH drug discovery and development programs (including BPN, HEAL PTDP, and URGenT) - Key personnel must have at least 10 years of relevant experience and advanced scientific degrees - Quantities: - 4-5 SME consultants required - Unique/Notable Requirements: - Deep expertise in CMC for gene-based biologics - Support for regulatory filings, project milestone feedback, and manufacturing oversight - Detailed capability statements required from interested firms - Contract includes a base year plus two one-year option periods - No specific OEMs or commercial product vendors are named in the solicitation - NAICS code: 541690 (Other Scientific and Technical Consulting Services)

Description

The National Institutes of Health (NIH), Office of the Director (OD) is conducting a market survey to determine the availability and technical capability of qualified small businesses, including 8(a) small businesses, small, disadvantaged businesses, woman-owned small businesses, service-disabled veteran-owned small businesses or HUBZone small businesses capable of providing the services of Gene-Based Therapeutics development subject matter expert (SME) consultants to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. Interested firms with the capability of providing all the required services shall submit a capability statement to assist the Government in determining in accordance with the Federal Acquisition Regulation 19.104-1. The intended procurement will be classified under North American Industrial Classification (NAICS) code 541690 with a size standard of $19m. All respondents are required to identify their firm’s size and type of business. Interested firms responding to this market survey must provide (a) capability statement demonstrating their experience, skills and capability to fulfill the Government’s requirements for the above. The capability statement shall be in sufficient enough details so that the Government can determine the experience and capability of your firm to provide the items and services in this posting/notice. Offers must also be accompanied by applicable descriptive literature, delivery timeframe, warranties and other information that demonstrates that the offer meets all the foregoing requirements. Capability statements must include the name and telephone number, and email address of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to the market survey that do not provide sufficient information for evaluation will be considered non-responsive. A copy of the capability statement must be received via email to robinsti@mail.nih.gov Attn: Tina Robinson prior to 10:30 am eastern daylight time on August 19, 2026. Capability statement must reference solicitation# 75N98026R00148. Submission by email must also reference solicitation # 75N98026R00148 on the subject line of the email. Any questions must be sent via email to robinsti@mail.nih.gov and must include solicitation# 75N98026R00148 on the subject line of email. Capability statements, etc will not be returned to firm/sender. This synopsis is for information and planning purposes and is not to be construed as a commitment by the Government, nor will the Government pay for information solicited.

View original listing